Latest Lancet Infectious Diseases Stories
Lower doses of the antimalarial drug primaquine are as effective as higher doses in reducing malaria transmission.
A clinical study published in the Lancet Infectious Diseases shows for the first time that an oral cholera vaccine (ShancholTM) provides sustained protection against cholera in humans for up to five years.
Poor quality antimalarial drugs lead to drug resistance and inadequate treatment that pose an urgent threat to vulnerable populations, according to a National Institutes of Health study published May 22 in The Lancet Infectious Diseases journal.
A research team led by St. Michael's Hospital's Dr. Kamran Khan is teaming up with British authorities to anticipate and track the risk for an infectious disease outbreak at the London Olympics this summer.
Americans lining up for their annual flu shot might want to consider that the vaccines may be far less effective than thought, according to a new study published in The Lancet Infectious Diseases.
According to Anna R. Giuliano, Ph.D., program leader in cancer epidemiology at Moffitt Cancer Center in Tampa, Fla., and colleagues in the Netherlands, earlier circumcision of males in South Africa may be a positive step in slowing the spread of both HIV and the human papillomavirus (HPV).
Researchers are claiming that a new "superbug" of MRSA is infecting cattle in Britain due to an over-use of antibiotics by dairy farmers.
If you want to improve HIV testing rates in remote rural areas, get the community involved, says UCLA's Thomas Coates, who has directed a new study examining HIV testing programs in communities in Africa and Southeast Asia.
A large clinical trial comparing treatments for typhoid has recommended the use of gatifloxacin, a new generation and affordable antibiotic.
- A handkerchief.
- In general, any miraculous portrait of Christ.